Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$356K Sell
4,832
-3,727
-44% -$281K 0.17% 79
2020
Q1
$628K Buy
8,559
+274
+3% +$21.5K 0.24% 62
2019
Q4
$720K Sell
8,285
-34
-0.4% -$2.79K 0.19% 54
2019
Q3
$668K Buy
8,319
+262
+3% +$21K 0.18% 63
2019
Q2
$644K Sell
8,057
-399
-5% -$30.6K 0.16% 70
2019
Q1
$668K Buy
8,456
+93
+1% +$6.96K 0.16% 74
2018
Q4
$610K Sell
8,363
-22
-0.3% -$1.55K 0.14% 73
2018
Q3
$568K Sell
8,385
-4
-0% -$255 0.12% 78
2018
Q2
$486K Sell
8,389
-1,494
-15% -$84.3K 0.11% 87
2018
Q1
$514K Buy
+9,883
New +$534K 0.15% 70

Other funds holding MRK

Private Vista's MRK Position: Q2 2020 in Review

Private Vista reduced its Merck (MRK) stake by 44% in Q2 2020, selling an estimated $281K and leaving 4,832 shares worth $356K. The position accounts for 0.17% of the portfolio, ranked #79.

Private Vista first reported a position in MRK in Q1 2018 and has held it in 10 quarters since. The position peaked at $720K in Q4 2019. 2,496 funds tracked by Wall St. Rank hold MRK as of Q2 2020.

  • Private Vista held 4,832 shares of Merck worth $356K as of Q2 2020.
  • Private Vista sold 3,727 Merck shares in Q2 2020, an estimated $281K.
  • Merck made up 0.17% of Private Vista's portfolio in Q2 2020, its #79 holding.
  • Private Vista first reported a position in Merck in Q1 2018 and has held it in 10 quarters since.
  • Private Vista's Merck position peaked at $720K in Q4 2019.
  • 2,496 funds tracked by Wall St. Rank held Merck as of Q2 2020.

Based on Private Vista's 13F filing for Q2 2020, filed 31 Jul 2020.